Cargando…

Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation

The insulin-like growth factor-1 (IGF-1) signaling pathway is crucial for the regulation of growth and development. The correct processing of the IGF-1Ea prohormone (proIGF-1Ea) and the IGF-1 receptor (IGF-1R) peptide precursor requires proper N-glycosylation. Deficiencies of N-linked glycosylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Patria, Laura, Annibalini, Giosuè, Morrone, Amelia, Ferri, Lorenzo, Saltarelli, Roberta, Galluzzi, Luca, Diotallevi, Aurora, Bocconcelli, Matteo, Donati, Maria Alice, Barone, Rita, Guerrini, Renzo, Jaeken, Jaak, Stocchi, Vilberto, Barbieri, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873121/
https://www.ncbi.nlm.nih.gov/pubmed/35211808
http://dx.doi.org/10.1007/s00018-022-04180-x
_version_ 1784657395218120704
author Di Patria, Laura
Annibalini, Giosuè
Morrone, Amelia
Ferri, Lorenzo
Saltarelli, Roberta
Galluzzi, Luca
Diotallevi, Aurora
Bocconcelli, Matteo
Donati, Maria Alice
Barone, Rita
Guerrini, Renzo
Jaeken, Jaak
Stocchi, Vilberto
Barbieri, Elena
author_facet Di Patria, Laura
Annibalini, Giosuè
Morrone, Amelia
Ferri, Lorenzo
Saltarelli, Roberta
Galluzzi, Luca
Diotallevi, Aurora
Bocconcelli, Matteo
Donati, Maria Alice
Barone, Rita
Guerrini, Renzo
Jaeken, Jaak
Stocchi, Vilberto
Barbieri, Elena
author_sort Di Patria, Laura
collection PubMed
description The insulin-like growth factor-1 (IGF-1) signaling pathway is crucial for the regulation of growth and development. The correct processing of the IGF-1Ea prohormone (proIGF-1Ea) and the IGF-1 receptor (IGF-1R) peptide precursor requires proper N-glycosylation. Deficiencies of N-linked glycosylation lead to a clinically heterogeneous group of inherited diseases called Congenital Disorders of Glycosylation (CDG). The impact of N-glycosylation defects on IGF-1/IGF-1R signaling components is largely unknown. In this study, using dermal fibroblasts from patients with different CDG [PMM2-CDG (n = 7); ALG3-CDG (n = 2); ALG8-CDG (n = 1); GMPPB-CDG (n = 1)], we analyzed the glycosylation pattern of the proIGF-1Ea, IGF-1 secretion efficiency and IGF-1R signaling activity. ALG3-CDG, ALG8-CDG, GMPPB-CDG and some PMM2-CDG fibroblasts showed hypoglycosylation of the proIGF-1Ea and lower IGF-1 secretion when compared with control (CTR). Lower IGF-1 serum concentration was observed in ALG3-CDG, ALG8-CDG and in some patients with PMM2-CDG, supporting our in vitro data. Furthermore, reduced IGF-1R expression level was observed in ALG3-CDG, ALG8-CDG and in some PMM2-CDG fibroblasts. IGF-1-induced IGF-1R activation was lower in most PMM2-CDG fibroblasts and was associated with decreased ERK1/2 phosphorylation as compared to CTR. In general, CDG fibroblasts showed a slight upregulation of Endoplasmic Reticulum (ER) stress genes compared with CTR, uncovering mild ER stress in CDG cells. ER-stress-related gene expression negatively correlated with fibroblasts IGF-1 secretion. This study provides new evidence of a direct link between N-glycosylation defects found in CDG and the impairment of IGF-1/IGF-1R signaling components. Further studies are warranted to determine the clinical consequences of reduced systemic IGF-1 availability and local activity in patients with CDG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04180-x.
format Online
Article
Text
id pubmed-8873121
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-88731212022-03-02 Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation Di Patria, Laura Annibalini, Giosuè Morrone, Amelia Ferri, Lorenzo Saltarelli, Roberta Galluzzi, Luca Diotallevi, Aurora Bocconcelli, Matteo Donati, Maria Alice Barone, Rita Guerrini, Renzo Jaeken, Jaak Stocchi, Vilberto Barbieri, Elena Cell Mol Life Sci Original Article The insulin-like growth factor-1 (IGF-1) signaling pathway is crucial for the regulation of growth and development. The correct processing of the IGF-1Ea prohormone (proIGF-1Ea) and the IGF-1 receptor (IGF-1R) peptide precursor requires proper N-glycosylation. Deficiencies of N-linked glycosylation lead to a clinically heterogeneous group of inherited diseases called Congenital Disorders of Glycosylation (CDG). The impact of N-glycosylation defects on IGF-1/IGF-1R signaling components is largely unknown. In this study, using dermal fibroblasts from patients with different CDG [PMM2-CDG (n = 7); ALG3-CDG (n = 2); ALG8-CDG (n = 1); GMPPB-CDG (n = 1)], we analyzed the glycosylation pattern of the proIGF-1Ea, IGF-1 secretion efficiency and IGF-1R signaling activity. ALG3-CDG, ALG8-CDG, GMPPB-CDG and some PMM2-CDG fibroblasts showed hypoglycosylation of the proIGF-1Ea and lower IGF-1 secretion when compared with control (CTR). Lower IGF-1 serum concentration was observed in ALG3-CDG, ALG8-CDG and in some patients with PMM2-CDG, supporting our in vitro data. Furthermore, reduced IGF-1R expression level was observed in ALG3-CDG, ALG8-CDG and in some PMM2-CDG fibroblasts. IGF-1-induced IGF-1R activation was lower in most PMM2-CDG fibroblasts and was associated with decreased ERK1/2 phosphorylation as compared to CTR. In general, CDG fibroblasts showed a slight upregulation of Endoplasmic Reticulum (ER) stress genes compared with CTR, uncovering mild ER stress in CDG cells. ER-stress-related gene expression negatively correlated with fibroblasts IGF-1 secretion. This study provides new evidence of a direct link between N-glycosylation defects found in CDG and the impairment of IGF-1/IGF-1R signaling components. Further studies are warranted to determine the clinical consequences of reduced systemic IGF-1 availability and local activity in patients with CDG. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00018-022-04180-x. Springer International Publishing 2022-02-24 2022 /pmc/articles/PMC8873121/ /pubmed/35211808 http://dx.doi.org/10.1007/s00018-022-04180-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Di Patria, Laura
Annibalini, Giosuè
Morrone, Amelia
Ferri, Lorenzo
Saltarelli, Roberta
Galluzzi, Luca
Diotallevi, Aurora
Bocconcelli, Matteo
Donati, Maria Alice
Barone, Rita
Guerrini, Renzo
Jaeken, Jaak
Stocchi, Vilberto
Barbieri, Elena
Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
title Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
title_full Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
title_fullStr Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
title_full_unstemmed Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
title_short Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation
title_sort defective igf-1 prohormone n-glycosylation and reduced igf-1 receptor signaling activation in congenital disorders of glycosylation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873121/
https://www.ncbi.nlm.nih.gov/pubmed/35211808
http://dx.doi.org/10.1007/s00018-022-04180-x
work_keys_str_mv AT dipatrialaura defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT annibalinigiosue defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT morroneamelia defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT ferrilorenzo defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT saltarelliroberta defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT galluzziluca defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT diotalleviaurora defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT bocconcellimatteo defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT donatimariaalice defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT baronerita defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT guerrinirenzo defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT jaekenjaak defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT stocchivilberto defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation
AT barbierielena defectiveigf1prohormonenglycosylationandreducedigf1receptorsignalingactivationincongenitaldisordersofglycosylation